Safety study of SPOT-mRNA01 injection in healthy people
Part of Skin clinical trials.
This trial tests a new mRNA medicine called SPOT-mRNA01 given as a shot under the skin. It aims to see if it is safe and tolerable in healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You do not have any skin problems, infections, or recent cosmetic treatments on the injection areas.
- You are not pregnant or breastfeeding, and you agree to avoid pregnancy if applicable.
- You have no history of severe allergic reactions to mRNA products or anesthetics.
- You have not taken part in another drug trial in the last 3 months.
- You are generally healthy and don't have heavy smoking, alcohol, or drug abuse history.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a food supplement can improve skin health in people with normal to dry skin. You would take the supplement or a placebo every day and have your skin checked over a few weeks.
This trial tests an investigational drug called SPN01 to see if it is safe and how the body processes it. It includes both healthy volunteers and people with colorectal cancer who are scheduled for surgery.
This is an early-stage trial testing a new type of treatment called mRNA therapy that helps your body make missing proteins. Researchers are enrolling healthy volunteers to understand how safe and well-tolerated this approach is.
This trial tests a single dose of an experimental medicine called EB070 in healthy people. It checks how the drug moves through the body and if it causes side effects. You may be able to join if you are a generally healthy adult.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
This is an early-stage safety test of a new injectable drug (SSS68) in healthy volunteers with no serious medical conditions. Researchers will give one dose under the skin and monitor how your body tolerates it over time.
Hear when a new Skin Aging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.